Clinical Trial Update: Thrombin Generation and Platelet Activation in CRS/HIPEC

View source ↗

Summary

Clinical trial evaluating thrombin generation and platelet activation during CRS/HIPEC has completed, involving mesothelioma and other peritoneal surface malign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Peritoneal Carcinomatosis
• Pseudomyxoma Peritonei

Snippet

Sponsor: Ziekenhuis Oost-Limburg | Conditions: Mesothelioma; Peritoneum, Pseudomyxoma Peritonei | Status: COMPLETED